Research Article

Usefulness of Cathepsin S to Predict Risk for Obstructive Sleep Apnea among Patients with Type 2 Diabetes

Table 1

Baseline clinical characteristics of the study population.

ParametersControl ()Non-OSA&T2D ()OSA&non-T2D ()OSA&T2D () value

Age (years)50.0 (38.0-64.0)58.0 (54.0-60.0)51.0 (46.0-56.5)54.0 (46.5-57.0)0.055
Male, (%)28 (65.1)10 (66.7)51 (77.3)28 (82.4)0.287
BMI (kg/m2)24.6 (22.2-29.0)24.3 (21.9-26.4)26.6 (24.2-28.8)26.7 (24.0-28.4)0.095
SBP (mmHg)120.0 (114.0-134.0)115.0 (109.0-130.0)129.0 (117.8-137.3)128.5 (119.0-139.3)0.067
DBP (mmHg)75.0 (69.0-85.0)70.0 (65.0-78.0)83.0 (75.0-92.3)§82.0 (77.8-89.0)††<0.001
Current smoker, (%)11 (25.6)5 (33.3)20 (30.3)17 (50.0)0.129
Drinker, (%)5 (11.6)4 (26.7)16 (24.2)11 (32.4)0.147
LVEF (%)60.0 (60.0-68.0)65.0 (62.0-68.0)67.0 (63.0-70.0)§§64.0 (59.5-68.0)£0.002
Neck circumference (cm)39.0 (36.0-41.0)35.0 (33.8-42.0)41.0 (37.0-43.0)43.5 (41.3-46.0)†††££<0.001
ESS score0.0 (0.0-3.0)6.0 (0.0-9.0)11.0 (8.0-15.0)§§§11.0 (7.8-15.0)††<0.001
AHI (events/h)3.1 (2.1-3.9)3.5 (2.3-7.3)38.5 (26.2-59.6)§§§47.5 (29.6-73.1)†††<0.001
Lowest SaO2 (%)92.0 (91.0-93.0)92.0 (88.0-93.0)80.0 (70.0-86.3)§§§82.0 (68.5-86.3)†††<0.001
Mean SaO2 (%)97.0 (95.8-98.0)96.0 (95.0-96.0)94.0 (90.0-95.1)§§§93.5 (92.0-95.0)††<0.001
CT90 (%)0.0 (0.0-0.0)0.0 (0.0-0.2)6.4 (0.5-16.8)§§§4.9 (0.2-20.6)††<0.001
Arousal index (events/h)0.7 (0.0-3.2)3.5 (0.3-6.7)36.7 (12.3-58.1)§§§11.9 (7.2-16.7)<0.001

Data are presented as median (interquartile range) or (%), unless otherwise stated. §§§, §§, and § between OSA&non-T2D and control. †††, ††, and between OSA&T2D and non-OSA&T2D. £££, ££, and £ between OSA&T2D and OSA&non-T2D. OSA: obstructive sleep apnea; T2D: type 2 diabetes; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; LVEF: left ventricular ejection fraction; ESS: Epworth Sleepiness Scale; AHI: apnea-hypopnea index; SaO2: arterial oxygen saturation; CT90: percentage of cumulative time with oxygen saturation below 90%.